Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
13.82B | 13.44B | 10.78B | 4.80B | 1.64B | 8.49B | Gross Profit |
3.42B | 3.88B | 3.04B | 791.10M | -66.90M | 2.45B | EBIT |
1.71B | 2.06B | 1.44B | -339.60M | -839.40M | 1.13B | EBITDA |
2.48B | 3.06B | 2.28B | 325.30M | -467.90M | 1.82B | Net Income Common Stockholders |
1.66B | 1.92B | 1.31B | -240.80M | -1.02B | 648.70M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.75B | 4.11B | 4.66B | 3.12B | 3.77B | 3.16B | Total Assets |
16.37B | 17.18B | 16.41B | 12.33B | 14.75B | 13.25B | Total Debt |
2.70B | 2.75B | 4.12B | 5.43B | 4.21B | 3.64B | Net Debt |
-51.40M | -1.13B | 516.90M | 2.78B | 1.64B | 1.97B | Total Liabilities |
8.20B | 9.56B | 10.76B | 7.68B | 9.78B | 8.04B | Stockholders Equity |
8.17B | 7.61B | 5.64B | 4.65B | 4.97B | 5.21B |
Cash Flow | Free Cash Flow | ||||
1.42B | 766.00M | 1.98B | -2.74B | 910.50M | 423.20M | Operating Cash Flow |
2.97B | 3.16B | 3.89B | -2.45B | 2.11B | 2.06B | Investing Cash Flow |
-1.17B | -1.56B | -1.90B | 937.10M | -918.10M | -1.02B | Financing Cash Flow |
-1.61B | -1.33B | -1.05B | 1.62B | -297.40M | -883.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $7.46B | 19.86 | 9.31% | ― | 12.56% | 69.33% | |
75 Outperform | $23.57B | 14.73 | 21.21% | 1.74% | 5.39% | 92.99% | |
74 Outperform | $1.51B | 18.00 | 15.12% | ― | 5.18% | ― | |
63 Neutral | $17.31B | 38.71 | 4.50% | 2.46% | 5.34% | -6.20% | |
62 Neutral | $8.11B | 13.34 | 1.17% | 3.02% | 4.16% | -15.14% | |
58 Neutral | $8.22B | 11.28 | -21.27% | ― | 2.70% | 2.20% | |
47 Neutral | $2.16B | ― | -26.60% | ― | -3.50% | -148.99% |